![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- Curry S L, Schlaerth J B, Kohorn E I, Boyce J B, Gore H, Twiggs L B, et al. Hormonal contraception and trophoblastic sequelae after hydatidiform mole (a Gynecologic Oncology Group Study). American Journal of Obstetrics and Gynecology 1989; 160: 805–811
- Fowler D J, Lindsay I, Seckl M J, Sebire N J. Routine pre-evacuation ultrasound diagnosis of hydatidiform mole: experience of more than 1000 cases from a regional referral center. Ultrasound in Obstetrics and Gynecology 2006; 27: 56–60
- Kim J H, Park D C, Bae S N, Namkoong S E, Kim S J. Subsequent reproductive experience after treatment for gestational trophoblastic disease. Gynecologic Oncology 1998; 71: 108–112
- Pisal N, Tidy J, Hancock B. Gestational trophoblastic disease: is intensive follow up essential in all women?. British Journal of Obstetrics and Gynaecology 2004; 111: 1449–1451
- RCOG. Green top guideline No. 38. The management of gestational trophoblastic neoplasia. RCOG, London 2004
- Savage P. Molar pregnancy. The Obstetrician and Gynaecologist 2008; 10: 3–8